Published Date – 24 April 2025
Women As One is pleased to announce the winners of the 2025 Mentorship Awards, which recognize six exceptional women physicians who will lead impactful clinical projects addressing key challenges in cardiovascular care.
Sponsored by AstraZeneca, BridgeBio, and Novo Nordisk, the 2025 Mentorship Awards support cross-institutional collaborations designed to create lasting change in the field of cardiology. Over the next 12 months, awardees will work on projects spanning three high-priority clinical areas:
Each pairing consists of a current cardiology fellow paired with an experienced mentor, selected through a rigorous and competitive application process. These partnerships promote mentorship, a critical driver of career development for women in cardiology, while generating meaningful progress in cardiovascular medicine.
Sponsored by
This team will work to close the diagnostic and treatment gaps for Transthyretin Amyloidosis (ATTR), a condition that remains underdiagnosed, particularly in underserved populations. Their work will aim to improve health equity and patient outcomes across diverse communities.
National Taiwan University Hospital, Taiwan
Yi-Hsin Hung, MD, is a final-year cardiology fellow at National Taiwan University Hospital. Dr. Hung focuses her clinical and research efforts on ATTR cardiac amyloidosis and cardio-oncology, with an emphasis on reducing diagnostic delays, enhancing treatment monitoring, and advancing equity-driven precision care.
Rimini Hospital, Italy
In 2001, Dr. Samuela Carugati qualified as a Medical Doctor at the University of Bologna, Bologna, Italy, and in 2005, she completed her specialization in Cardiology at the same institution.
Since 2007, she has served as a Consultant in the Department of Cardiology at Rimini Hospital, Romagna, Italy, in a permanent role as Dirigente Medico di I livello a tempo indeterminato, as defined by Italian law. Currently, she holds the position of Company Manager in the field of Cardiomyopathies within USL Romagna. She is also the Co-Chair of the Coordinator Area of the Heart Failure Board within the Italian Association of Cardiologists (ANMCO).
Since 2022, she has served as a Professor at the Cardiology School of the University of Ferrara, Italy.
At Rimini Hospital, she follows the Cardiomyopathy Outpatient and Heart Failure Clinic. Her clinical expertise includes performing cardiac magnetic resonance imaging, transesophageal echocardiography, and stress echocardiography, with a particular focus on patients with cardiomyopathies. She also provides coverage for the intensive care unit and cardiologic emergency department.
In addition to her clinical work, she is actively involved in clinical research and has published numerous studies in the fields of heart failure and cardiomyopathies.
Sponsored by
This mentorship pairing will focus on clinical research within Transthyretin Amyloid Cardiomyopathy (ATTR-CM), aiming to enhance early diagnosis and improve management strategies.
University of California San Francisco, United States of America
Dr. Pooja Prasad is an Advanced Heart Failure and Transplant cardiologist with clinical and research interests in cardiac amyloidosis, pulmonary hypertension and heart failure with preserved fraction. She earned her medical degree from the University of Rochester School of Medicine. She completed a residency in Internal Medicine at the University of California, Davis, followed by a fellowship in cardiology at Oregon Health and Science University and a fellowship in Advanced Heart Failure and Transplant Cardiology at UCSF. Dr. Prasad serves as an Assistant Clinical Professor at University of California, San Francisco and Principal Investigator on clinical trials investigating novel drugs for the treatment of HFpEF.
Massachusetts General Hospital, United States of America
Dr. Hanna K. Gaggin is a cardiologist, clinical investigator, and educator at Massachusetts General Hospital (MGH) and Harvard Medical School. She founded and directs the multidisciplinary MGH Amyloidosis Program, which provides both comprehensive care and research opportunities for patients with amyloidosis. With a focus on cardiac amyloidosis and heart failure, Dr. Gaggin leads and participates in single- and multi-center clinical trials, utilizing traditional clinical research approaches as well as emerging methods in machine learning and biomarker development.
After earning her medical degree from Eastern Virginia Medical School, Dr. Gaggin completed her Internal Medicine residency at the University of Virginia Health System. She then received an MPH in Quantitative Methods from the Harvard School of Public Health, followed by fellowships in cardiology at the University of Pittsburgh Medical Center and in clinical research at MGH. She joined the MGH and Harvard Medical School faculty in 2012. Dr. Gaggin is currently an Associate Professor of Medicine at Harvard Medical School.
Beyond her research, Dr. Gaggin is dedicated to educating and supporting the next generation of physicians. She serves as the Cardiology Subspecialty Core Educator for the MGH Internal Medicine residency and is the founder and co-editor of the MGH Cardiology Board Review books. In 2022, she was selected for the American College of Cardiology’s Emerging Faculty Leadership Academy and as an inaugural HeartShare fellow focused on data sciences. She also founded and directs the Junior Faculty Club Series at MGH, providing junior faculty with practical skills and guidance to grow their careers.
Sponsored by
This duo will address the presentation and management of Non-ST-Elevation Myocardial Infarction (NSTEMI) within U.S. healthcare systems. Their project will explore ways to streamline care, reduce delays in diagnosis, and improve patient outcomes.
Washington University School of Medicine, United States of America
Dr Shaikh is a Cardiology fellow at Washington University School of Medicine in Saint Louis. She was born and raised in Pakistan where her early medical education cemented an interest in the care of the underserved. She is passionate about studying disparities in cardiovascular care delivery with particular focus on rural health outcomes. Her other interests lie in the fields of heart failure, interventional cardiology and medical education.
Stanford University and VA Palo Alto Healthcare System, United States of America
Celina M. Yong, MD, MBA, MSc, FACC, FAHA, FSCAI is an Associate Professor at Stanford University School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Healthcare System. She leads an active health services research lab focused on using innovative approaches and scalable technologies to improve cardiovascular outcomes among all patients. She is Founder and Director of the VA-Cardiovascular Trials Consortium (VA-CTC). She serves as an Associate Editor for the Journal of the American College of Cardiology. She has also co-authored national scientific and expert consensus statements, including the ACC/AHA/SCAI Coronary Artery Revascularization Guidelines.
The Women As One Mentorship Awards not only celebrate clinical excellence but also reaffirm the importance of mentorship in supporting professional growth and gender equity in cardiology. Through these awards, we are helping to shape the next generation of cardiovascular leaders and drive measurable improvements in global patient care.
Congratulations to the 2025 Mentorship Award winners! We look forward to seeing the outcomes of your important work in the year ahead.
The Talent Directory is a global professional community explicitly tailored for women cardiologists across diverse medical specialties.
Join us to embark on a journey of professional growth, collaboration, and empowerment. Together, let’s redefine the future of medicine.